# Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia

> **NCT03391804** · PHASE2 · COMPLETED · sponsor: **Allena Pharmaceuticals** · enrollment: 15 (actual)

## Conditions studied

- Enteric Hyperoxaluria
- Primary Hyperoxaluria
- Hyperoxalemia

## Interventions

- **DRUG:** ALLN-177

## Key facts

- **NCT ID:** NCT03391804
- **Lead sponsor:** Allena Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-17
- **Primary completion:** 2019-12-13
- **Final completion:** 2019-12-13
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03391804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03391804, "Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03391804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*